Načítá se...
Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer
We tested the prognostic relevance of metabolic parameters and their relative changes in patients with metastatic colorectal cancer (mCRC) treated with monoclonal antibody and chemotherapy. SUV(max) (standardized uptake volume), SAM (standardized added metabolic activity) and TLG (total lesion glyco...
Uloženo v:
| Vydáno v: | Pathol Oncol Res |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Netherlands
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7772167/ https://ncbi.nlm.nih.gov/pubmed/32661836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12253-020-00865-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|